stockrowANI Pharmaceuticals, Inc. (ANIP) vs Trulieve Cannabis Corp. (TRLV)
- ANI Pharmaceuticals, Inc. ANIP 69.03 −3.66%
- Trulieve Cannabis Corp. TRLV 11.07 −4.57%
ANI Pharmaceuticals, Inc. and Trulieve Cannabis Corp. are both Drug Manufacturers Specialty & Generic companies. Trulieve Cannabis Corp. is the larger, with a market value of $2.1B against $1.6B — 1.3× the size. Trulieve Cannabis Corp. has negative trailing earnings, so its P/E is not meaningful; ANI Pharmaceuticals, Inc. trades at 13.3×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 25.9% against −9.09%. ANI Pharmaceuticals, Inc. has the higher net margin (11.2% vs −41.2%) and the higher return on invested capital (46.4% vs 0.00%). Across the 19 metrics below, ANI Pharmaceuticals, Inc. leads on 15 and Trulieve Cannabis Corp. on 4.
Valuation
Profitability
| Metric | ANIP | TRLV | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 61.06% | 60.64% | 53.51% |
| Operating margin | 15.99% | 0.00% | 0.00% |
| Net margin | 11.22% | (41.22%) | (2.45%) |
| Free cash flow margin | 19.72% | 22.43% | 0.00% |
| Return on equity | 20.45% | (45.52%) | (0.80%) |
| Return on assets | 7.85% | (17.61%) | (1.67%) |
| Return on invested capital | 46.43% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack